Developmental change in amygdala reactivity during adolescence / Johnna R. Swartz en The American Journal of Psychiatry, Año 2015 - Vol. 172 - No.3 (Marzo)

Público ISBD [artículo]  inThe American Journal of Psychiatry > Año 2015 - Vol. 172 - No.3 (Marzo) . - pp. 276–283 Título : Developmental change in amygdala reactivity during adolescence : effects of family history of depression and stressful life events Tipo de documento: texto impreso Autores: Johnna R. Swartz, Autor ; Douglas E. Williamson, Autor ; Ahmad R. Hariri, Autor Fecha de publicación: 2020 Artículo en la página: pp. 276–283 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Trastorno depresivo, Imágenes por resonancia magnética, Tecnicas psicologicas, Psicopatología, Estrés psicológico. Resumen: Although heightened amygdala reactivity is observed in patients with major depression, two critical gaps in our knowledge remain. First, it is unclear whether heightened amygdala reactivity is a premorbid vulnerability or a consequence of the disorder. Second, it is unknown how and when this neural phenotype develops. Link: ./index.php?lvl=notice_display&id=22261 [artículo] Developmental change in amygdala reactivity during adolescence : effects of family history of depression and stressful life events [texto impreso] / Johnna R. Swartz, Autor ; Douglas E. Williamson, Autor ; Ahmad R. Hariri, Autor . - 2020 . - pp. 276–283. Idioma : Inglés (eng) Idioma original : Inglés (eng) in The American Journal of Psychiatry > Año 2015 - Vol. 172 - No.3 (Marzo) . - pp. 276–283 Palabras clave: Trastorno depresivo, Imágenes por resonancia magnética, Tecnicas psicologicas, Psicopatología, Estrés psicológico. Resumen: Although heightened amygdala reactivity is observed in patients with major depression, two critical gaps in our knowledge remain. First, it is unclear whether heightened amygdala reactivity is a premorbid vulnerability or a consequence of the disorder. Second, it is unknown how and when this neural phenotype develops. Link: ./index.php?lvl=notice_display&id=22261

A double-blind, randomized study of olanzapine and olanzapine/fluoxetine combination for major depression with psychotic features / Anthony J. Rothschild en Journal of Clinical Psychopharmacology, Año 2004 - Vol. 24 - No. 4 (Agosto)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2004 - Vol. 24 - No. 4 (Agosto) . - pp. 365-373 Título : A double-blind, randomized study of olanzapine and olanzapine/fluoxetine combination for major depression with psychotic features Tipo de documento: texto impreso Autores: Anthony J. Rothschild, Autor ; Douglas E. Williamson, Autor ; Mauricio Tohen, Autor Fecha de publicación: 2023 Artículo en la página: pp. 365-373 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Benzodiacepinas, Trastorno Depresivo Mayor, Trastorno depresivo mayor, Fluoxetina, Trastornos psicóticos. Resumen: The purpose of this study was to compare the efficacy and safety of olanzapine (OLZ) monotherapy and an olanzapine/fluoxetine combination (OFC) with placebo (PLA) for unipolar major depression with psychotic features. Under a single protocol, two 8-week, double-blind trials were conducted at 27 sites. Patients (n = 124 trial 1, n = 125 trial 2) were randomized to 1 of 3 treatment groups: OLZ (5 to 20 mg/d), PLA, or OFC (olanzapine 5 to 20 mg/d + fluoxetine 20 to 80 mg/d). Link: ./index.php?lvl=notice_display&id=30948 [artículo] A double-blind, randomized study of olanzapine and olanzapine/fluoxetine combination for major depression with psychotic features [texto impreso] / Anthony J. Rothschild, Autor ; Douglas E. Williamson, Autor ; Mauricio Tohen, Autor . - 2023 . - pp. 365-373. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2004 - Vol. 24 - No. 4 (Agosto) . - pp. 365-373 Palabras clave: Benzodiacepinas, Trastorno Depresivo Mayor, Trastorno depresivo mayor, Fluoxetina, Trastornos psicóticos. Resumen: The purpose of this study was to compare the efficacy and safety of olanzapine (OLZ) monotherapy and an olanzapine/fluoxetine combination (OFC) with placebo (PLA) for unipolar major depression with psychotic features. Under a single protocol, two 8-week, double-blind trials were conducted at 27 sites. Patients (n = 124 trial 1, n = 125 trial 2) were randomized to 1 of 3 treatment groups: OLZ (5 to 20 mg/d), PLA, or OFC (olanzapine 5 to 20 mg/d + fluoxetine 20 to 80 mg/d). Link: ./index.php?lvl=notice_display&id=30948

---

1 (1 - 2 / 2)